Lomond Therapeutics Holdings, Inc.

This was the first-ever study in humans for a new oral drug called ZE50-0134. Its main goal was to check the drug's safety, how the body processes it, and its effects in 104 healthy adults. Volunteers received different single doses of the drug or a placebo, and researchers monit…

This early-stage study tested a new drug called ZE46-0134 in healthy volunteers to check its safety and how the body processes it. Researchers gave different doses to 112 healthy adults to monitor for side effects and measure drug levels in the blood. The study was completed and …